Potent hepatitis C inhibitors bind directly to NS5A and reduce its affinity for RNA

April 23, 2014

Ascher D.B., Wielens J., Nero T.L., et al.

Scientific Reports 2014, vol: 4(1) doi: 10.1038/srep04765

Abstract

Hepatitis C virus (HCV) infection affects more than 170 million people. The high genetic variability of HCV and the rapid development of drug-resistant strains are driving the urgent search for new direct-acting antiviral agents. A new class of agents has recently been developed that are believed to target the HCV protein NS5A although precisely where they interact and how they affect function is unknown. Here we describe an in vitro assay based on microscale thermophoresis and demonstrate that two clinically relevant inhibitors bind tightly to NS5A domain 1 and inhibit RNA binding. Conversely, RNA binding inhibits compound binding. The compounds bind more weakly to known resistance mutants L31V and Y93H. The compounds do not affect NS5A dimerisation. We propose that current NS5A inhibitors act by favouring a dimeric structure of NS5A that does not bind RNA.

View Publication

Topics: Virology, Monolith – MicroScale Thermophoresis, MST,  Publications

 

 

 

Previous Article
Looking for novel capsid protein multimerization inhibitors of feline immunodeficiency virus
Looking for novel capsid protein multimerization inhibitors of feline immunodeficiency virus

Up next
The three-fold axis of the HIV-1 capsid lattice is the species-specific binding interface for TRIM5α
The three-fold axis of the HIV-1 capsid lattice is the species-specific binding interface for TRIM5α

×

Sign up to receive
the latest NanoTemper news, product updates, event announcements and more

First Name
Last Name
Company Name
Country
State
Province
State
Region
State
Canton
Agree to Subscribe & Privacy Policy*
*I have fully read, understood and agree to the Privacy Policy. I accept the storing and processing of my personal data by NanoTemper as described in the Privacy Policy.

By completing this form, you provide us consent to contact you with educational content, news and information about our products, services and events. You may unsubscribe at any time.
Thank you!
Error - something went wrong!